Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2025) 110 EP1220 | DOI: 10.1530/endoabs.110.EP1220

1Ibn Rochd University Hospital of Casablanca, Morocco, Neurosciences and Mental Health Laboratory Faculty of Medicine and Pharmacy- University Hassan II – Casablanca-Morocco, Endocrinology, Diabetology, Nutrition and Metabolic Diseases Departement, Casablanca, Morocco


JOINT3679

Introduction: Acromegaly can manifest itself through very frequent degenerative rheumatological complications responsible for long-term after-effects. The objective To describe the rheumatological manifestations of acromegaly.

Patients and Methods: This is an retrospective study of 78 cases of acromegaly followed up in the endocrinology department of Ibn Rochd University Hospital from 2005 to 2024. Rheumatological complications were noted at diagnosis or during follow-up.

Results: The mean age was 45 years (18–72), the sex ratio: 0.33, the mean duration of the disease was 8 and a half years. The mean IGF-1 level was 582 ng/ml or 2.62 times the normal. The rheumatological manifestations like peripheral articular manifestations were dominated by knee pain in 55 patients (42.9%). Diffuse arthralgia was present in 5 acromegalic patients (3.9%), elbow pain in 7 patients (5.46%) and shoulder arthralgia in 3 patients (2.34%). Dorso-lumbar back pain, was present in 36 patients (28.08%) associated with unilateral sciatica in two patients. Carpal tunnel syndrome, were reported in 5 patients (3.9%). The phosphocalcic profile was without abnormality. The mean vitamin D level was 14.3 ng/dl. Bone densitometry showed osteopenia in 5 patients, osteoporosis in one patient and was normal in the rest of the patients.

Conclusion: The rheumatological manifestations linked to acromegaly include peripheral, axial and canal joint involvement, hence the importance of looking for them at the time of diagnosis and during follow-up in order to limit their impact on the functional prognosis of patients.

Volume 110

Joint Congress of the European Society for Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE) 2025: Connecting Endocrinology Across the Life Course

European Society of Endocrinology 
European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches